ApoA-I induced CD31 in bone marrow-derived vascular progenitor cells increases adhesion: Implications for vascular repair

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1781, Issue 11-12, 2008, Pages 703-709

  Mythreye, Karthikeyan ^a   Satterwhite, Lisa L ^b   Davidson, W Sean ^c   Goldschmidt Clermont, Pascal J ^d  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b Duke University   (United States)

^c Genome Research Institute   (United States)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Adhesion; ApoA I; Bone marrow cells (BMCs); CD31; Lineage minus; Vascular progenitor cell

Indexed keywords

APOLIPOPROTEIN A1; CD31 ANTIGEN; CHOLESTEROL; FIBRONECTIN; HIGH DENSITY LIPOPROTEIN;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; BINDING SITE; BRAIN CELL; CELL ADHESION; CELL DIFFERENTIATION; CELL LINEAGE; CELL POPULATION; CELL SHAPE; CELL SIZE; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; ENDOTHELIUM CELL; HEMATOPOIETIC STEM CELL; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; VASCULAR SURGERY;

ANIMALS; ANTIGENS, CD31; APOLIPOPROTEIN A-I; BRAIN; CELL ADHESION; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CELL SIZE; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; FIBRINOGEN; FLUORESCENT ANTIBODY TECHNIQUE; HEMATOPOIETIC STEM CELLS; HUMANS; LIPIDS; MICE; MICE, INBRED C57BL; STEM CELLS;

ANIMALIA;

EID: 56049101134     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbalip.2008.08.002     Document Type: Article

References (29)

1. Rubin E.M., Krauss R.M., Spangler E.A., Verstuyft J.G., and Clift S.M. Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI. Nature 353 (1991) 265-267
2. Plump A.S., Scott C.J., and Breslow J.L. Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 9607-9611
3. Lorenzi I., von Eckardstein A., Cavelier C., Radosavljevic S., and Rohrer L. Apolipoprotein A-I but not high-density lipoproteins are internalised by RAW macrophages: roles of ATP-binding cassette transporter A1 and scavenger receptor BI. J. Mol. Med. 86 2 (2008) 171-183
4. Weibel G.L., Alexander E.T., Joshi M.R., Rader D.J., Lund-Katz S., Phillips M.C., and Rothblat G.H. Wild-type ApoA-I and the Milano variant have similar abilities to stimulate cellular lipid mobilization and efflux. Arterioscler. Thromb. Vasc. Biol. 27 (2007) 2022-2029
5. Duverger N., Kruth H., Emmanuel F., Caillaud J.M., Viglietta C., Castro G., Tailleux A., Fievet C., Fruchart J.C., Houdebine L.M., and Denefle P. Inhibition of atherosclerosis development in cholesterol-fed human apolipoprotein A-I-transgenic rabbits. Circulation 94 (1996) 713-717
6. Belalcazar L.M., Merched A., Carr B., Oka K., Chen K.H., Pastore L., Beaudet A., and Chan L. Long-term stable expression of human apolipoprotein A-I mediated by helper-dependent adenovirus gene transfer inhibits atherosclerosis progression and remodels atherosclerotic plaques in a mouse model of familial hypercholesterolemia. Circulation 107 (2003) 2726-2732
7. Sata M., Saiura A., Kunisato A., Tojo A., Okada S., Tokuhisa T., Hirai H., Makuuchi M., Hirata Y., and Nagai R. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat. Med. 8 (2002) 403-409
8. Goodman J.W. Stem cells circulating in the blood. Rev. Eur. Etud. Clin. Biol. 15 (1970) 149-150
9. Libby P. Inflammation in atherosclerosis. Nature 420 (2002) 868-874
10. Hill J.M., Zalos G., Halcox J.P., Schenke W.H., Waclawiw M.A., Quyyumi A.A., and Finkel T. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N. Engl. J. Med. 348 (2003) 593-600
11. Rauscher F.M., Goldschmidt-Clermont P.J., Davis B.H., Wang T., Gregg D., Ramaswami P., Pippen A.M., Annex B.H., Dong C., and Taylor D.A. Aging, progenitor cell exhaustion, and atherosclerosis. Circulation 108 (2003) 457-463
12. Araki S., and Goto S. Age-associated changes in the serum level of apolipoproteins A-I and A-IV and the gene expression as revealed by fasting and refeeding in mice. Exp. Gerontol. 38 (2003) 499-506
13. Araki S., Okazaki M., and Goto S. Impaired lipid metabolism in aged mice as revealed by fasting-induced expression of apolipoprotein mRNAs in the liver and changes in serum lipids. Gerontology 50 (2004) 206-215
14. Panagotopulos S.E., Horace E.M., Maiorano J.N., and Davidson W.S. Apolipoprotein A-I adopts a belt-like orientation in reconstituted high density lipoproteins. J. Biol. Chem. 276 (2001) 42965-42970
15. Chute J.P., Muramoto G.G., Salter A.B., Meadows S.K., Rickman D.W., Chen B., Himburg H.A., and Chao N.J. Transplantation of vascular endothelial cells mediates the hematopoietic recovery and survival of lethally irradiated mice. Blood 109 (2007) 2365-2372
16. Chapman M.J., Assmann G., Fruchart J.C., Shepherd J., and Sirtori C. Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid-a position paper developed by the European Consensus Panel on HDL-C. Curr. Med. Res. Opin. 20 (2004) 1253-1268
17. Linsel-Nitschke P., and Tall A.R. HDL as a target in the treatment of atherosclerotic cardiovascular disease. Nat. Rev. Drug. Discov. 4 (2005) 193-205
18. Newman P.J., and Newman D.K. Signal transduction pathways mediated by PECAM-1: new roles for an old molecule in platelet and vascular cell biology. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 953-964
19. Albeda F.W., van der Meer J., and Vellenga E. Vascular proliferation as an unusual cause of hemorrhagic diathesis in myelofibrosis. Am. J. Clin. Pathol. 95 (1991) 564-566
20. Price D.T., and Loscalzo J. Cellular adhesion molecules and atherogenesis. Am. J. Med. 107 (1999) 85-97
21. Buttiglieri S., Pasqui D., Migliori M., Johnstone H., Affrossman S., Sereni L., Wratten M.L., Barbucci R., Tetta C., and Camussi G. Endothelization and adherence of leucocytes to nanostructured surfaces. Biomaterials 24 (2003) 2731-2738
22. Reedquist K.A., Ross E., Koop E.A., Wolthuis R.M., Zwartkruis F.J., van Kooyk Y., Salmon M., Buckley C.D., and Bos J.L. The small GTPase, Rap1, mediates CD31-induced integrin adhesion. J. Cell Biol. 148 (2000) 1151-1158
23. Brooks-Wilson A., Marcil M., Clee S.M., Zhang L.H., Roomp K., van Dam M., Yu L., Brewer C., Collins J.A., Molhuizen H.O., Loubser O., Ouelette B.F., Fichter K., Ashbourne-Excoffon K.J., Sensen C.W., Scherer S., Mott S., Denis M., Martindale D., Frohlich J., Morgan K., Koop B., Pimstone S., Kastelein J.J., Genest Jr. J., and Hayden M.R. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat. Genet. 22 (1999) 336-345
24. Remaley A.T., Stonik J.A., Demosky S.J., Neufeld E.B., Bocharov A.V., Vishnyakova T.G., Eggerman T.L., Patterson A.P., Duverger N.J., Santamarina-Fojo S., and Brewer Jr. H.B. Apolipoprotein specificity for lipid efflux by the human ABCAI transporter. Biochem. Biophys. Res. Commun. 280 (2001) 818-823
25. Tang C., Vaughan A.M., and Oram J.F. Janus kinase 2 modulates the apolipoprotein interactions with ABCA1 required for removing cellular cholesterol. J. Biol. Chem. 279 (2004) 7622-7628
26. Green P.H., Glickman R.M., Riley J.W., and Quinet E. Human apolipoprotein A-IV. Intestinal origin and distribution in plasma. J. Clin. Invest. 65 (1980) 911-919
27. Li Y., Dong J.B., and Wu M.P. Human ApoA-I overexpression diminishes LPS-induced systemic inflammation and multiple organ damage in mice. Eur. J. Pharmacol. 590 1-3 (2008) 417-422
28. Calabresi L., Rossoni G., Gomaraschi M., Sisto F., Berti F., and Franceschini G. High-density lipoproteins protect isolated rat hearts from ischemia-reperfusion injury by reducing cardiac tumor necrosis factor-alpha content and enhancing prostaglandin release. Circ. Res. 92 (2003) 330-337
29. Gomaraschi M., Calabresi L., Rossoni G., Iametti S., Franceschini G., Stonik J.A., and Remaley A.T. Anti-inflammatory and cardioprotective activities of synthetic high-density lipoprotein containing apolipoprotein A-I mimetic peptides. J. Pharmacol. Exp. Ther. 324 (2008) 776-783